Domaine de Maîtrise :
Biopathologie et Recherche Biomédicale

Domaine d’intérêt :
Biopathologie et Recherche Biomédicale**, Nouvelles Technologies - Ingénierie - Systèmes d’Information et IA

Les publications :
Articles d’oncologie depuis 2014 (date de création du laboratoire MedBiotech) 1. Breast cancer in Morocco: a literature review. M Slaoui, R Razine, A Ibrahimi, M Attaleb, ME Mzibri, M Amrani. Asian Pac J Cancer Prev 15 (3), 1067-1074 (2014) 2. MatSAM: a Matlab implementation for Significance Analysis of Microarrays. E Nimpaye, O Kaissi, TR Singh, B Vannier, A Ibrahimi, A Moussa. International Journal forComputational Biology (IJCB) Vol.3, No.2 pp. 49-51 (2014) 3. Investigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case–control study. J Rahoui, A Laraqui, Y Sbitti, N Touil, A Ibrahimi, B Ghrab, A Al Bouzidi, ... Medical Oncology 31 (9), 193 (2014) 4. The single nucleotide polymorphism+ 936 C/T VEGF is associated with human epidermal growth factor receptor 2 expression in Moroccan breast cancer women. J Rahoui, Y Sbitti, N Touil, A Laraqui, A Ibrahimi, B Rhrab, A Al Bouzidi, ... Medical Oncology 31 (12), 336 (2014) 5. Determination and validation of mTOR kinase-domain 3D structure by homology modeling. W Lakhlili, G Chevé, A Yasri, A Ibrahimi. OncoTargets and therapy 8, 1923 (2015) 6. Structure–activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches. W Lakhlili, A Yasri, A Ibrahimi. OncoTargets and therapy 9, 7345 (2016) 7. H3ABioNet, a sustainable pan-African bioinformatics network for human heredity and health in Africa. NJ Mulder, E Adebiyi, R Alami, A Benkahla, J Brandful, S Doumbia, A Ibrahimi... Genome research 26 (2), 271-277 (2016) 8. Docking analysis of verteporfin with YAP WW domain. I Kandoussi, JT Wiame Lakhlili, A Ibrahimi. Bioinformation 13 (7), 237 (2017) 9. In silico inhibition studies of AXL kinase by curcumin and its natural derivatives. G Fatima, A Loubna, L Wiame, I Azeddine. J Appl Bioinforma Comput Biol 6 3, 2 (2017) 10. Three-dimensional Structure Prediction of the Human LMTK3 Catalytic Domain in DYG-in Conformation. L Allam, W Lakhlili, Z Tarhda, J Akachar, F Ghrifi, HE Amri, A Ibrahimi. J Biomol Res Ther 6 (151), 2 (2017) 11. Anticandidal, antibacterial, cytotoxic and antioxidant activities of Calendula arvensis flowers. AM Abudunia, I Marmouzi, MEA Faouzi, Y Ramli, J Taoufik, N El Madani, ... Journal de mycologie medicale 27 (1), 90-97 (2017) 12. Molecular screening and docking analysis of LMTK3and AKT1 combined inhibitors. L Allam, G Fatima, L Wiame, EA Hamid, I Azeddine. Bioinformation 14 (9), 499 (2018) 13. A review on PIM kinases in tumors. H Arrouchi, W Lakhlili, A Ibrahimi. Bioinformation 15 (1), 40 (2019) 14. Re-positioning of known drugs for Pim-1 kinase target using molecular docking analysis. H Arrouchi, W Lakhlili, A Ibrahimi. Bioinformation 15 (2), 116 1 (2019) 15. Virtual docking screening and QSAR studies to explore AKT and mTOR inhibitors acting on PI3K in cancers. I Kandoussi, O Benherrif, W Lakhlili, J Taoufik, A Ibrahimi. Contemporary Oncology/Współczesna Onkologia 24 (1) (2020)